ORVILLE JACOB A 4

What Happened

• Orville Jacob A, Executive Vice President & GM, Screening at Exact Sciences (EXAS), was granted 38,707 shares as a derivative award on February 25, 2026. The report shows an acquisition price of $0.00 (award of restricted stock units), so no cash was paid. The filing (Accession 0001193125-26-082839) was made on February 27, 2026.

Key Details

• Transaction date: 2026-02-25; Filing date: 2026-02-27 (appears timely).
• Transaction type/code: Award/Grant (A); reported acquisition of 38,707 derivative shares (RSUs) at $0.00.
• Shares reported on this Form 4: 102,162 common shares beneficially owned.
• Additional holdings (per footnote): 45,288 vested and unvested options and restricted stock units (each RSU = right to one share).
• Vesting: these restricted stock units vest in four equal annual installments beginning February 25, 2027.
• No sale, open-market purchase, or option exercise was reported in this filing.

Context

• RSUs are compensation awards that convert to common shares only as they vest; they are not an immediate cash purchase or sale. This grant increases future potential ownership if the RSUs vest according to the schedule. The filing provides disclosure of compensation-related equity grants rather than an active market trade.